QualiCOP: an open-label, prospective, observational study of glatiramer acetate in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Ziemssen, T. [1 ]
Calabrese, P. [2 ]
Penner, I. -K. [2 ]
Carroll, C. A. [3 ]
Apfel, R. [4 ]
机构：
[1] Univ Clin Carl Gustav Carus, Dresden, Germany
[2] Univ Basel, Basel, Switzerland
[3] Teva Pharmaceut Ind, Global Hlth Econ & Outcomes Res, Overland Pk, KS USA
[4] Teva Pharmaceut Ind, Berlin, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP4140
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [1] QualiCOP: an open-label, prospective, observational study of glatiramer acetate in patients with relapsing-remitting multiple sclerosis
    Ziemssen, T.
    Calabrese, P.
    Penner, I. -K.
    Carroll, C. A.
    Apfel, R.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 : S229 - S229
  • [2] A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate
    Moreau, T.
    Brudon, F.
    Debouverie, M.
    Heinzlef, O.
    Lebrun-Frenay, C.
    Gury, C.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
  • [3] Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis
    Simpson, D
    Noble, S
    Perry, C
    [J]. BIODRUGS, 2003, 17 (03) : 207 - 210
  • [4] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [5] Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
    Dene Simpson
    Stuart Noble
    Caroline Perry
    [J]. BioDrugs, 2003, 17 : 207 - 210
  • [6] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis?
    不详
    [J]. Drugs & Therapy Perspectives, 1998, 11 (10) : 1 - 5
  • [7] Effects of Glatiramer Acetate on Spasticity in Previously Interferon-β-Treated and Treatment-Naive Patients With Relapsing-Remitting Multiple Sclerosis: A Prospective, Nonrandomized, Open-Label, Uncontrolled, Observational Pilot Study
    Eustasio Meca-Lallana, Jose
    de Mingo-Casado, Pedro
    Amorin-Diaz, Manuel
    Luisa Martinez-Navarro, Maria
    Fernandez Barreiro, Andres
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (06) : 1061 - 1066
  • [8] Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
    Taskapilioglu, Ozlem
    Turan, Asli Bahar
    Albas, Murat
    Turan, Omer Faruk
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (01) : 17 - 20
  • [9] Long-term (up to 26 years), open-label, compassionate use study of glatiramer acetate in relapsing-remitting multiple sclerosis
    Miller, A
    Spada, V
    Beerkircher, D
    Kreitman, RR
    Kadosh, S
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2005, 11 : S84 - S84
  • [10] Fatigue in relapsing-remitting multiple sclerosis patients using glatiramer acetate - FOCUS Study
    Jongen, PJH
    Carton, H
    Sanders, EACM
    Seeldrayers, P
    Fredrikson, S
    Andersson, M
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S257 - S257
12345